Literature DB >> 23926724

New possible pathways in improving outcome and patient satisfaction after TKA.

Hendrik P Delport1, Jos Vander Sloten, Johan Bellemans.   

Abstract

Patient dissatisfaction after TKA has not been improved dramatically since the introduction of new alignment (navigation, custom guides) and balancing techniques. Orthopaedic surgeons consider the ligaments as essentially passive stabilizing structures. However, during the activities of daily living, the joints are stabilized primarily by our muscle actions that both move and stabilize the joints. Isometric motion of the joint does not cause the distance separating the bone attachments to change. The practical importance of isometry is confirmed by the fact that ligaments are elongated irreversibly if the strain exceeds a given level (5%). In ligament surgery as well as in TKA, the concept of isometry is highly important. In this paper we wish to highlight the fact that the role of the soft tissue envelope goes beyond structural and mechanical support. The presence of mechano- and nocireceptors in the structures around the human knee joint has long been reported but is underrecognised by TKA surgeons.

Entities:  

Mesh:

Year:  2013        PMID: 23926724

Source DB:  PubMed          Journal:  Acta Orthop Belg        ISSN: 0001-6462            Impact factor:   0.500


  2 in total

1.  Restoration of constitutional alignment in TKA leads to more physiological strains in the collateral ligaments.

Authors:  Hendrik Delport; Luc Labey; Bernardo Innocenti; Ronny De Corte; Jos Vander Sloten; Johan Bellemans
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2014-04-06       Impact factor: 4.342

2.  Using a patella reduced technique while balancing a TKA results in restored physiological strain in the collateral ligaments: an ex vivo kinematic analysis.

Authors:  Ignace Ghijselings; Orcun Taylan; Hendrik Pieter Delport; Josh Slane; Hans Van den Wyngaert; Alex Demurie; Lennart Scheys
Journal:  Arch Orthop Trauma Surg       Date:  2021-07-03       Impact factor: 3.067

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.